Successful hyperbaric oxygen treatment of a patient with a HeartMate III left ventricular assist device.

IF 0.8 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Diving and hyperbaric medicine Pub Date : 2023-06-30 DOI:10.28920/dhm53.2.147-150

Arun Ilancheran, Ian Millar, Theo Tsouras

引用次数: 0

Abstract

A 53-year-old woman with a HeartMate III left ventricular assist device (LVAD) was successfully treated under hyperbaric conditions for haemorrhagic cystitis. The HeartMate III LVAD inserted in this patient had not previously been tested or certified for use under hyperbaric conditions. To our knowledge this is the first report of the HeartMate III LVAD being used to support a patient undergoing hyperbaric treatment. The overview detailed here of the safety and technical aspects of managing this patient for hyperbaric treatment was possible due to the collaboration of a multi-disciplinary team. We believe that our experience has demonstrated a pathway to safe hyperbaric treatment of patients dependent upon a HeartMate III LVAD.

查看原文本刊更多论文

使用HeartMate III左心室辅助装置成功对一名患者进行高压氧治疗。

一名使用HeartMate III左心室辅助装置（LVAD）的53岁女性在高压条件下成功治疗出血性膀胱炎。该患者植入的HeartMate III LVAD此前未进行高压条件下使用的测试或认证。据我们所知，这是HeartMate III LVAD用于支持接受高压治疗的患者的第一份报告。由于多学科团队的合作，这里详细介绍了管理该患者进行高压治疗的安全和技术方面。我们相信，我们的经验已经证明了对依赖HeartMate III LVAD的患者进行安全高压治疗的途径。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diving and hyperbaric medicine 医学-公共卫生、环境卫生与职业卫生

CiteScore

1.70

自引率

22.20%

发文量

审稿时长

>12 weeks

期刊介绍： Diving and Hyperbaric Medicine (DHM) is the combined journal of the South Pacific Underwater Medicine Society (SPUMS) and the European Underwater and Baromedical Society (EUBS). It seeks to publish papers of high quality on all aspects of diving and hyperbaric medicine of interest to diving medical professionals, physicians of all specialties, scientists, members of the diving and hyperbaric industries, and divers. Manuscripts must be offered exclusively to Diving and Hyperbaric Medicine, unless clearly authenticated copyright exemption accompaniesthe manuscript. All manuscripts will be subject to peer review. Accepted contributions will also be subject to editing.